Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisRoss L. Levine, D. Gary Gilliland, Jan Cools et al.|Cancer Cell|2005Cited by 3k
JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphomaKatrien Van Roosbroeck, Iwona Włodarska|Blood|2011Cited by 107
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-Cell LymphomaIwona Włodarska|PLoS ONE|2014Cited by 64